Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Jul 6, 2023; 11(19): 4692-4697
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4692
Table 1 Use of minocycline and its effects in Morbihan disease
Sex/age (yr)
Clinical features
Mast cell
Dose
Course
Effect
M/51[10]Erythema and edema on left upper eyelid with complete left ptosis -N/AN/AIneffective
M/70[6] Erythematous edema on forehead, nose and periorbital areas-200 mg/d, 300 mg/dOver 2 moIneffective
M/54[12]Erythema and edema on cheek and periorbital area-N/A6 to 7 moIneffective
M/30[13]Edema on bilateral eyelids-100 mg/d, 50 mg/d7 moDiscontinued due to insignificant improvement and abnormal liver enzyme levels
M/74[7]Swelling on right cheek and left upper eyelid+50 mg/d, 100 mg/d4 moPartially effective
F/64[15]Swelling on entire face +100 mg/d6 moSignificantly effective
M/38[18]Periorbital indurated edema+N/A3 moIneffective
M/56[8] Swelling on both eyelids and cheeks+100 mg/d7 moEffective but discontinued due to abnormal liver enzyme levels
F/41[4]Erythematous edema on upper eyelids, forehead, nose and cheeks +N/AN/AEffective
F/40[11]Bilateral periorbital edema and intermittent blurry vision-N/AA short periodDiscontinued due to urticaria
N/A/88[1]Swelling on left eyelidN/AN/AN/APartially improved
M/28[14]Edema and erythema on periorbital region, nose and cheeks; telangiectasias and pustules-100 mg/dOver 2 moPartially improved